Labcorp Globalization Symposium
In Pursuit of Answers: The Navigation Guide to Your Global Drug Development Journey
Advance Your Clinical Trials Beyond APAC
Register now for the streaming.
Wednesday 16 November 2022 | 10:00 – 13:50 JST
We are excited to invite you to this exclusive symposium to help you strengthen your global clinical trials by:
- How to plan a successful global drug development strategy
- Can we de-risk your global filling in the VUCA drug development environment
- Pursuit of personalized medicine with the right biomarker strategy
- Real-world examples from C>/ CDx Studies with global and Japanese perspectives
You will have the opportunity to learn from in-depth presentations addressing challenges in today’s evolving global drug development landscape.
The educational sessions are designed to share our experiences as well as provide innovative ideas for globalization challenges associated with clinical trials. During the seminar, you are also invited to have lunch and chat with our experts to resolve your queries.
Sessions
Simultaneous translation will be provided to in-person attendees
Time(JST)
Sessions
Speakers
10:00 - 11:00
On-site registration (tea and light refreshments will be served)
11:00 - 11:10
Labcorp: A Trusted Source for Your Globalization Answers
Catherine Ohura
Vice President, General Manager, Labcorp Japan
11:10 - 11:50
Top Considerations for Your Global Drug Development Strategy
- Impact of COVID-19 on drug development
- Important regulatory and clinical landscape considerations in a post-pandemic world
- Developing the right development strategy
- Why the choosing the right partner is important to the success of your global trial
Bill Hanlon
President CDCS, Clinical Therapeutic and Regulatory Sciences; CSO
11:50 - 12:20
How to De-Risk Your Global Filing in VUCA Drug Development Environment
- Patient diversity and inclusion
- Add on value with DCT to accelerate the patient recruitment and site identification
- Breaking through barriers to reach our minority communities
Linda Ross
Associate Director, Digital Strategy and Solutions, Decentralized Clinical Trials
12:20 - 12:30
Short break for lunchbox distribution
12:30 - 13:10
Outlook on Your Biomarker Solution and CDx Strategy as You Advance for Global Trials
- Regulatory environment ( FDA +PMDA guidelines and strategy recommendation)
- How to embed the right strategy in early clinical development stages
Prasanth Reddy
Senior Vice President,
Global Enterprise Head of Oncology
13:10 - 13:30
Key Learnings from C>/ CDx Development Model with Global and Japan
Kazuya Kurachi
Senior Director,
Global Regulatory Operations Japan
13:30 - 13:45
Q&A
Moderator: Andrew Fleming
Vice President, Enterprise Business Development
13:45 - 13:50
Closing remarks
Andrew Fleming
Vice President, Enterprise Business Development
About Labcorp
Labcorp is a global life sciences company that supports the missions of service providers, pharmaceutical companies, researchers and patients in making clear and confident healthcare decisions. Through our comprehensive diagnostics and drug development capabilities, we provide insights that drive innovations to improve health and improve lives. With more than 75,000 employees, we serve clients in more than 100 countries.
Labcorp respects your privacy.